Table 4.
Detailed information on the independent risk factors in the failure group
| Failure reasons | Baseline serum β-hCG, IU/L | Type of CSP | Interval between MTX and surgery, day |
Fetal heartbeat before surgery |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| > 94,000 | ≤ 94,000 | I | II | III | > 7 | ≤ 7 | Yes | No | ||||
|
emergency surgery (n = 9) |
3 | 6 | 3 | 6 | 0 | 9 | 0 | 0 | 9 | |||
|
surgical planning change (n = 13) |
7 | 6 | 1 | 2 | 10 | 8 | 5 | 3 | 10 | |||
|
vaginal bleeding post-discharge (n = 4) |
4 | 0 | 1 | 3 | 0 | 2 | 2 | 0 | 4 | |||
|
residual pregnancy tissue (n = 8) |
3 | 5 | 3 | 4 | 1 | 5 | 3 | 0 | 8 | |||
|
persistent abnormal serum β-hCG (n = 7) |
3 | 4 | 3 | 3 | 1 | 4 | 3 | 0 | 7 | |||